These results, together with a former report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,two aid the strategy of targeting ACKR3 as a novel method to modulate the opioid procedure, which could open new therapeutic avenues for opioid-connected Disea